121 related articles for article (PubMed ID: 38468288)
1. UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5.
Li J; Liang Y; Zhou S; Chen J; Wu C
Breast Cancer Res; 2024 Mar; 26(1):44. PubMed ID: 38468288
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis.
Liu S; González-Prieto R; Zhang M; Geurink PP; Kooij R; Iyengar PV; van Dinther M; Bos E; Zhang X; Le Dévédec SE; van de Water B; Koning RI; Zhu HJ; Mesker WE; Vertegaal ACO; Ovaa H; Zhang L; Martens JWM; Ten Dijke P
Clin Cancer Res; 2020 Mar; 26(6):1460-1473. PubMed ID: 31857432
[TBL] [Abstract][Full Text] [Related]
3. miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.
Zhou W; Song F; Wu Q; Liu R; Wang L; Liu C; Peng Y; Mao S; Feng J; Chen C
PLoS One; 2017; 12(4):e0176395. PubMed ID: 28437471
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer.
Zou H; Luo J; Guo Y; Tong T; Liu Y; Chen Y; Xiao Y; Ye L; Zhu C; Deng L; Wang B; Pan Y; Li P
Cell Mol Life Sci; 2023 Jan; 80(2):41. PubMed ID: 36633714
[TBL] [Abstract][Full Text] [Related]
6. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
[TBL] [Abstract][Full Text] [Related]
7. Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.
Anbalagan M; Sheng M; Fleischer B; Zhang Y; Gao Y; Hoang V; Matossian M; Burks HE; Burow ME; Collins-Burow BM; Hangauer D; Rowan BG
Mol Cancer Res; 2017 Nov; 15(11):1491-1502. PubMed ID: 28751463
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.
Yu Y; Qi J; Xiong J; Jiang L; Cui D; He J; Chen P; Li L; Wu C; Ma T; Shao S; Wang J; Yu D; Zhou B; Huang D; Schmitt CA; Tao R
Theranostics; 2019; 9(3):761-777. PubMed ID: 30809307
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop.
Shen Y; Zhu Q; Xiao M; Yin L; Feng W; Feng J; He J; Li P; Chen X; Ding W; Zhong J; Zeng Z; Xie Z; Liu J; Zu X
Cell Death Dis; 2022 Aug; 13(8):749. PubMed ID: 36042208
[TBL] [Abstract][Full Text] [Related]
10. USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5.
Wu Y; Qin J; Li F; Yang C; Li Z; Zhou Z; Zhang H; Li Y; Wang X; Liu R; Tao Q; Chen W; Chen C
J Biol Chem; 2019 Nov; 294(47):17837-17847. PubMed ID: 31624151
[TBL] [Abstract][Full Text] [Related]
11. TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer.
Good CR; Panjarian S; Kelly AD; Madzo J; Patel B; Jelinek J; Issa JJ
Cancer Res; 2018 Aug; 78(15):4126-4137. PubMed ID: 29891505
[TBL] [Abstract][Full Text] [Related]
12. The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1.
Wang C; Nie Z; Zhou Z; Zhang H; Liu R; Wu J; Qin J; Ma Y; Chen L; Li S; Chen W; Li F; Shi P; Wu Y; Shen J; Chen C
Oncotarget; 2015 Jul; 6(19):17685-97. PubMed ID: 25970772
[TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer.
Umeh-Garcia M; O'Geen H; Simion C; Gephart MH; Segal DJ; Sweeney CA
Br J Cancer; 2022 Aug; 127(3):436-448. PubMed ID: 35440669
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer.
Xiang T; Li L; Yin X; Yuan C; Tan C; Su X; Xiong L; Putti TC; Oberst M; Kelly K; Ren G; Tao Q
PLoS One; 2012; 7(1):e29783. PubMed ID: 22279545
[TBL] [Abstract][Full Text] [Related]
15. Curcumin induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines.
Al-Yousef N; Shinwari Z; Al-Shahrani B; Al-Showimi M; Al-Moghrabi N
Oncol Rep; 2020 Mar; 43(3):827-838. PubMed ID: 32020216
[TBL] [Abstract][Full Text] [Related]
16. DANCR Induces Cisplatin Resistance of Triple-Negative Breast Cancer by KLF5/p27 Signaling.
Su A; Yao K; Zhang H; Wang Y; Zhang H; Tang J
Am J Pathol; 2023 Mar; 193(3):248-258. PubMed ID: 36509121
[TBL] [Abstract][Full Text] [Related]
17. UCHL1 promotes cancer stemness in triple-negative breast cancer.
Tian C; Liu Y; Liu Y; Hu P; Xie S; Guo Y; Wang H; Zhang Z; Du L; Lei B; Wang Y; Xue L; Zhang D; Su J; Zhang X; Zhang R; Chen J; Zhang X; Chen L; Li M; Jia Q; Song J; Liu J
Pathol Res Pract; 2022 Dec; 240():154235. PubMed ID: 36434856
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.
Ummanni R; Jost E; Braig M; Lohmann F; Mundt F; Barett C; Schlomm T; Sauter G; Senff T; Bokemeyer C; Sültmann H; Meyer-Schwesinger C; Brümmendorf TH; Balabanov S
Mol Cancer; 2011 Oct; 10():129. PubMed ID: 21999842
[TBL] [Abstract][Full Text] [Related]
19. USP22 Contributes to Chemoresistance, Stemness, and EMT Phenotype of Triple-Negative Breast Cancer Cells by egulating the Warburg Effect via c-Myc Deubiquitination.
Li J; Gao R; Zhang J
Clin Breast Cancer; 2023 Feb; 23(2):162-175. PubMed ID: 36528490
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling.
Tang J; Li Y; Sang Y; Yu B; Lv D; Zhang W; Feng H
Oncogene; 2018 Aug; 37(34):4723-4734. PubMed ID: 29760406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
